Hey Superheroes, Despite there being only 4 more trading sessions until Christmas (eek!) there is still plenty going down. We have had cooling inflation and a small tech rebound in the United States, Crude Oil dropping to a four year low despite escalation in the Caribbean and closer to home, both CBA and NAB have […]
Hey Superheroes, The U.S. Fed delivered its third rate cut of the year this week, dropping rates by 0.25% to a range of 3.5%-3.75%. But the move came with a warning: just one more cut is expected in 2026 and another in 2027. Markets rallied cautiously as investors eye the possibility of a Santa Rally […]
Hey Superheroes, Next week sees both the Reserve Bank of Australia and the U.S. Federal Reserve meet to decide their respective cash rates. Australian investors look set to be disappointed with the rate set to remain at 3.6% while U.S. investors are eagerly anticipating an early Christmas present from Jerome Powell in the form of […]
Google's Gemini 3 sparks record rally as Alphabet gains $1 trillion in market value. Meanwhile, Oracle crashes 30% on debt fears and Dell beats on AI server demand. Plus: Helloworld bids for Webjet.
Wild week for markets: Nvidia crushed earnings with $65B guidance, but tech stocks still tanked. Meanwhile, Buffett just dropped $5B on Alphabet. What's the Oracle of Omaha seeing that markets missed? Get your 3-minute market hit.
Elon Musk just saw shareholders approve a $1T pay package while Sydney-based Iren signed a massive deal with Microsoft. Get your 3-minute market hit.
NAB fell after its full year profit missed expectations while Breville climbed on upbeat product demand.
The RBA’s holding rates steady as inflation cools. Here’s what it means for Aussies, markets and investors heading into 2025.
Goodman reaffirmed its 9% earnings target as data centre demand drives growth while Medibank expanded its healthcare footprint with a $159m GP network deal.
RBA keeps rate at 3.60%. Novonix tumbled after Stellantis scrapped a major supply deal while City Chic climbed on stronger ANZ sales.
ANZ warned of a $1.1 billion hit under new CEO Nuno Matos as he pushes through a major restructure while Mayne Pharma plunged over 31% after the Treasurer moved to block its U.S. takeover.
Meta’s Q3 earnings took a hit from Trump’s tax bill and ballooning AI costs. Four of the Mag 7 reported this week. Get your 3-minute market hit.